deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 1-arm NCT03255694

A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature

A Phase 2 Study Extension Period of Pegylated Somatropin (PEG-somatropin) in the Treatment of Children With Idiopathic Short Stature: An Open, Non-controlled Observational Study.

Sponsor: Affiliated Hospital of Jiangnan University

Conditions Dwarfism
Interventions PEG-somatropin
Updated 10 times since 2017 Last updated: Aug 12, 2025 Started: May 12, 2017 Primary completion: Jun 30, 2030 Completion: Jun 30, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Dwarfism, this trial is ongoing. The trial is conducted by Affiliated Hospital of Jiangnan University and has accumulated 10 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotRecruiting~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotRecruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotRecruiting~Oct 2021 – ~Jul 2023 · 21 months · monthly snapshotRecruiting~Jul 2023 – ~Sep 2023 · 2 months · monthly snapshotActive Not Recruiting~Sep 2023 – ~Oct 2023 · 30 days · monthly snapshotActive Not Recruiting~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotActive Not Recruiting~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotActive Not Recruiting~Sep 2025 – present · 12 months · monthly snapshotActive Not Recruiting

Change History

10 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Active Not Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  4. Oct 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

  5. Sep 2023 — Oct 2023 [monthly]

    Active Not Recruiting PHASE2

▶ Show 5 earlier versions

  1. Jul 2023 — Sep 2023 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Oct 2021 — Jul 2023 [monthly]

    Recruiting PHASE2

  3. Jan 2021 — Oct 2021 [monthly]

    Recruiting PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Recruiting PHASE2

  5. Sep 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

    First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Affiliated Hospital of Jiangnan University
  • Beijing Children's Hospital
  • Changchun GeneScience Pharmaceutical Co., Ltd.
  • Children's Hospital of Fudan University
  • Children's Hospital of Soochow University
  • Hunan Children's Hospital
  • Jiangxi Province Children's Hospital
  • Shanghai Children's Hospital
  • The Children's Hospital of Zhejiang University School of Medicine
  • The First Affiliated Hospital with Nanjing Medical University
  • The First Hospital of Jilin University
  • Tongji Hospital
  • Wuxi Women's & Children's Hospital
Data source: Changchun GeneScience Pharmaceutical Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations